Bio-Techne Corporation reported earnings results for the third quarter and nine months ended March 31, 2022. For the third quarter, the company reported sales was USD 290.38 million compared to USD 243.55 million a year ago. Net income was USD 60.74 million compared to USD 45.78 million a year ago. Basic earnings per share from continuing operations was USD 0.3875 compared to USD 0.295 a year ago. Diluted earnings per share from continuing operations was USD 0.37 compared to USD 0.28 a year ago.
For the nine months, sales was USD 817.37 million compared to USD 672 million a year ago. Net income was USD 210.53 million compared to USD 125.45 million a year ago. Basic earnings per share from continuing operations was USD 1.34 compared to USD 0.81 a year ago. Diluted earnings per share from continuing operations was USD 1.28 compared to USD 0.7775 a year ago.